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Abstract
Spontaneous clearance of hepatitis C virus (HCV) occurs in ,30% of acute infections. Host genetics play a major role in HCV
clearance, with a strong effect of single nucleotide polymorphisms (SNPs) of the IL28B gene already found in different
populations, mostly infected with viral genotypes 1 and 3. Egypt has the highest prevalence of HCV infection in the world,
which is mostly due to viral genotype 4. We investigated the role of several IL28B SNPs in HCV spontaneous clearance in an
Egyptian population. We selected nine SNPs within the IL28B genomic region covering the linkage disequilibrium (LD) block
known to be associated with HCV clearance in European populations. These SNPs were genotyped in 261 HCV-infected
Egyptian subjects (130 with spontaneous clearance and 131 with chronic infection). The most associated SNPs were
rs12979860 (P=1.6610
27) and the non-synonymous IL28B SNP, rs8103142 (P=1.6610
27). Interestingly, three SNPs at the
two bounds of the region were monomorphic, reducing the size of the LD block in which the causal variants are potentially
located to ,20 kilobases. HCV clearance in Egypt was associated with a region of IL28B smaller than that identified in
European populations, and involved the non-synonymous IL28B SNP, rs8103142.
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Introduction
Hepatitis C virus (HCV) infects 170 million people worldwide
and is thus a major Public Health problem [1,2]. End-stage
chronic hepatitis C is the leading cause of liver transplantation in
developed countries and more than 350,000 people die from
HCV-related liver diseases each year [1,2]. Spontaneous clearance
of hepatitis C virus (HCV) occurs in ,30% of acute infections
[3,4]. Differences in HCV clearance and persistence have been
associated with viral factors and several host factors, including
ethnicity, age, sex and co-infection with human immunodeficiency
virus or hepatitis B virus [4,5]. Host genetics also play a major
role, with a strong effect of variants of the IL28B gene, which
encodes IFN-l3, on spontaneous HCV clearance reported in
populations of different backgrounds, mostly infected with viral
genotypes 1 and 3 (reviewed in [3]). The same IL28B variants are
also strongly associated with HCV clearance under treatment
[6,7].
Egypt has the highest prevalence of HCV infection of any
country in the world, with a seroprevalence ranging from 10% in
children to 45% in adults [8,9]. More than 90% of HCV infections
in Egypt involve genotype 4 [8,9]. One study recently reported an
association between the most studied single nucleotide poly-
morphism (SNP) of IL28B, rs12979860, and the spontaneous
clearance of HCV genotype 4 in an Egyptian sample [10]. We
investigated the role of a panel of IL28B SNPs in the spontaneous
clearance of HCV in a larger Egyptian cohort. We found that the
clearance effect was restricted to a region of IL28B smaller than
that identified in European populations and that this effect also
involved rs8103142, a non synonymous IL28B SNP.
Methods
This study combined data from two Egyptian cohorts. The first
included 3994 individuals from a large epidemiological study in
a village of the Nile delta, the details of which have been described
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seropositive for HCV and 305 of them had positive PCR test.
None of the seropositive individuals have been treated at the time
of the study. Ninety-six RNA samples had previously been
sequenced in this cohort, and 95 (99%) of these samples were of
HCV genotype 4 [11]. From the overall cohort, we selected 188
independent unrelated HCV-infected subjects defined on the basis
of two positive serological tests [11]. Individuals with positive PCR
test for viral RNA were further classified as ‘‘chronically infected’’,
whereas those with negative results were considered to have
cleared the virus spontaneously. Subjects of this cohort were not
tested for HBV infection, but it could be noted that several studies
in Nile Delta villages, including this one, reported a rather low
prevalence on HBV infection (2%–8%) [12,13,14]. The second
cohort included 73 patients with symptomatic acute HCV
infection recruited from Cairo hospitals in the context of a study
that has been described elsewhere [15,16]. In these subjects,
spontaneous clearance was defined as the loss of HCV RNA from
the serum in the absence of treatment, based on two consecutive
negative viral PCR results, together with subsequent negative tests,
including at least one more than one year after the acute episode.
Chronic infection was defined as the presence of HCV RNA in the
serum in all PCR tests over a period of at least one year after the
acute episode. Twenty-seven RNA samples from this cohort had
previously been sequenced, and 24 (89%) were of HCV genotype
4 [15,16]. Subjects of this cohort were tested for HBV infection, as
previously described [17], and out of the 73 present patients, only
one was found to be HBV infected. Finally, the overall sample of
261 subjects consisted of 130 subjects with spontaneous clearance
and 131 with chronic infection. All these subjects were not tested
for HIV infection, but HIV seroprevalence was found to be quite
low (,0.1%) in the general Egyptian population aged of 15 to 49
years (http://www.unaids.org/en/regionscountries/countries/
egypt) as well as among injection drug users (,0.6%) [18]. The
study was approved by the Institutional Review Board of the
Egyptian Ministry of Population and Health. Signed informed-
consent documents were obtained from all study participants
before they entered the study.
We genotyped a total of nine SNPs within the IL28B genomic
region (Figure 1A). We first included the three SNPs (rs12980275,
rs12979860, rs8099917) most frequently reported to be associated
with HCV clearance in previous studies. We then explored the
long-range linkage disequilibrium (LD) (500 kilobases on either
side of IL28B) of these three SNPs, using the European CEU
population available data from HapMap (http://www.hapmap.
org) and 1000 Genomes project [19] databases. We selected the
two most distant SNPs (rs958039, rs576832) in LD, with an
r
2.0.3, with any of the three initial SNPs. Within the
chromosome 19 region defined by these two SNPs, we included
three additional regularly spaced SNPs (rs4803217, rs4803222,
rs10424607) in LD, with an r
2.0.3, with any of the three initial
SNPs. Finally, we also selected the non synonymous SNP
rs8103142 not present in the public databases but reported to be
in strong LD with rs12979860 in European populations [20].
Illumina GoldenGate genotyping was carried out with VeraCode
technology (Illumina). For genetic markers, we applied the
following quality control criteria: call rate ,90%, Hardy-
Weinberg P-value,0.005 or low-quality genotype clustering. No
individuals were excluded on the basis of genotyping call rate.
Univariate tests of association between the genotyped SNPs and
the clearance/persistence status of HCV infection were carried out
using PLINK software [21]. Multivariate analysis was performed
with the LOGISTIC procedure implemented in SAS software
v.9.2 (SAS Institute, Cary, North Carolina, USA). Pairwise LD
between SNPs and haplotype frequencies were estimated with
PLINK [21] and Haploview 4.1 (http://www.broad.mit.edu/
mpg/haploview) software.
Results
All the SNPs studied satisfied the quality control filters in all 261
individuals, and the allelic frequencies are reported in figure 1A.
Three SNPs at the 39 (rs958039) and the 59 (rs10424607 and
rs576832) boundaries of the IL28B region were monomorphic,
whereas the frequencies of the other SNPs were similar to those
observed in European populations. Univariate association analyses
showed that the six polymorphic SNPs in the Egyptian population
were strongly associated with spontaneous HCV clearance
(Figure 1A). The most significant results were obtained with an
additive genetic model, with rs12979860 [odds ratio of presenting
HCV clearance (OR) for CT vs.TT (or CC vs.CT)=2.84 (95%
confidence interval: 1.87–4.30); P=1.6610
27] and rs8103142
[OR=2.76 (1.84–4.13); P=1.6610
27]. Association analyses con-
ductedforthesetwoSNPsseparatelyinourtwocohortsprovidedvery
similarresultsintermsofallelefrequenciesandodds-ratiosindicating
that possible HBV co-infection in some patients of our first cohort
could not affect these results. In our whole sample, and taking
rs8103142 as an example, the proportion of subjects with HCV
clearance was much higher in subjects carrying the protective TT
genotype(66%ofclearers)thaninthosewithCT(39%ofclearers)or
CC (23% of clearers) genotypes (Figure 1B).
We then carried out multivariate regression analysis with the six
polymorphic SNPs. When the most significant SNP (rs12979860)
was introduced into the model, the other five SNPs ceased to be
significantly associated with clearance, confirming that this
association was based on a single signal. We then estimated
pairwise LD between the six polymorphic SNPs. The LD pattern
of these SNPs, and that of rs12979860 in particular (see Figure
S1A), in this Egyptian population was similar to that in European
populations (see Figure S1B). The non-synonymous SNP
rs8103142 could not be included in this comparison, as no
genotyping data were available for the CEU population. The r
2 for
the relationship between rs8103142 and rs12979860 was estimat-
ed at 0.96 in another European population [20] and 0.88 in our
Egyptian population. The three remaining SNPs were mono-
morphic in the Egyptian population, whereas they form part of the
IL28B cluster associated with HCV clearance in the European
population (Figure 1A). Interestingly, these three SNPs are located
at the 39 (rs958039) and 59 (rs10424607 and rs576832) ends of the
genomic region corresponding to IL28B (Figure 1A), reducing the
size of the LD block in the Egyptian population by about one
third. Overall, these observations suggest that the causal SNPs
underlying the association with HCV clearance are located in
a smaller region of ,20 kilobases located between rs958039 and
rs10424607 rather than in a long-range LD block.
Finally, we estimated haplotype frequencies derived from the six
polymorphic SNPs in this population. The objective of this
haplotype analysis was not to test formally for differences in
haplotype frequencies between subjects with clearance and those
with chronic infection, but to further refine our univariate results
by providing the general haplotype structure of this Egyptian
sample. Seven haplotypes had an estimated frequency .0.02 in
the whole sample. Based on differences in haplotype frequencies
between subjects with spontaneous clearance and those with
chronic infection, these seven haplotypes could be classified into
two protective (favouring clearance) haplotypes (one of which was
much more common than the other) and five ‘‘at risk’’ haplotypes
(conferring a predisposition to chronic infection) (Figure 2). The
IL28B Variants and HCV Clearance in Egypt
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e38578two protective haplotypes differed only in terms of the allele of
SNP rs4803217. In comparisons with the alleles present in the two
protective haplotypes, only two SNPs presented the alternative
allele in all five at risk haplotypes, discrepancies being observed for
the others. The two SNPs with consistently different alleles
between the protective and at risk haplotypes were rs12979860
Figure 1. SNPs genotyped in the IL28B genomic region and their association with spontaneous clearance. A. The top panel shows the
IL28B genomic region bounded by rs958039 and rs576832, its position on chromosome 19 (39,730,301–39,759,282 base pairs), and the respective
positions of the genotyped SNPs. The bottom panel shows the frequencies of the minor allele for each SNP in the European and Egyptian
populations. European frequencies are estimated from the CEU data from Hapmap and the 1000 Genomes project. Egyptian frequencies are
estimated from the population from the overall sample studied here and separately for the two groups of individuals (HCV clearance and HCV
persistence). Odds ratio for HCV clearance (OR) and 95% confidence intervals (CI 95%), together with P-values for univariate tests with the additive
genetic model are also shown for each SNP. B. Proportion of spontaneous clearance as a function of genotype at SNPs rs12979860 and rs8103142.
doi:10.1371/journal.pone.0038578.g001
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consistent with the univariate association results and supports the
view that the core of the association is dependent on these two
SNPs, the effect of which are indistinguishable in this sample.
Discussion
These results confirm the major role of IL28B variants in the
spontaneous clearance of HCV genotype 4 infection in an
Egyptian population. In particular, the magnitude of the
association with rs12979860 observed is similar to that reported
in many studies conducted on HCV genotype 1 infection [5,20]
and with the only previous study of HCV genotype 4 infection in
an Egyptian population [10]. Our refined analysis, including eight
additional IL28B SNPs, showed that the LD block of the IL28B
SNP cluster associated with HCV clearance was shorter than that
in European populations. In particular, this analysis reduces the
chromosomal region in which the causal SNPs are potentially
located to about 20 kilobases of the IL28B genomic region,
excluding the IL28A genomic region. Finally, both our univariate
and haplotype analyses clearly showed that the core association
depended on two SNPs, rs12979860 and rs8103142. SNP
rs8103142 replaces a lysine residue by an arginine residue at
position 70 (K70R) in IFN-l3, a substitution predicted to be
benign by Polyphen [22]. Further functional studies are required
to identify the causal SNPs underlying this strong association and
the precise mechanisms of IL28B involvement in HCV infection.
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